Cart
sales@molnova.com
6-Methyl-3-pyridinecarboxaldehyde
CAS No. 65873-72-5
6-Methyl-3-pyridinecarboxaldehyde( —— )
Catalog No. M36398 CAS No. 65873-72-5
6-Methyl-3-pyridinecarboxaldehyde (6-Methoxynicotinaldehyde) has partial antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-Methyl-3-pyridinecarboxaldehyde
-
NoteResearch use only, not for human use.
-
Brief Description6-Methyl-3-pyridinecarboxaldehyde (6-Methoxynicotinaldehyde) has partial antitumor activity.
-
Description6-Methoxypyridine-3-carbaldehyde is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65873-72-5
-
Formula Weight137.14
-
Molecular FormulaC7H7NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=NC=C(C=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-06446846
PF?06446846 is a potent and selective PCSK9 inhibitor?PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.?
-
3-Bromopyruvic acid
3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
-
Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
